Dr. Radisic is a Professor and Canada Research Chair at the University of Toronto, a recipient of Queen Elizabeth II Diamond Jubilee Medal, and Fellow of the Royal Society of Canada. She brings 15+ years of technical and management experience, leading research and large scale initiatives at the University of Toronto. Previously she co-founded Tara Biosystems.
Susan Bruggemann, MBA
Susan brings both biotech startup experience and 20+ years of leadership experience in Corporate and Commercial Finance and Operations across various Fortune 100 companies, including Kraft and Xylyx Bio Inc.
David Elmaleh, PhD
Co-Founder & Board Director
Dr. Elmaleh is an Associate Professor at Harvard Medical School, renowned molecular imaging expert and founder of several successful biotech companies including AZTherapies, Mersana, MolecularInsights and PureTech Health.
Chief Business Officer
Karen brings 25 years’ experience in the life sciences, medical device and aesthetics industries, most recently as CEO of Cytrellis Biosystems. She has a track record of launching exceptionally successful products and building commercial teams both at Cytrellis as well as Cynosure and EMD Millipore.
Sargol brings significant experience in the development of peptides and biomaterials.
Business Development Assoc.
Alaa, a PhD candidate in pharmacology, brings product and industry knowledge.
Leonard Miller, MD
Dr. Miller is a Clinical Instructor in Surgery, Harvard Medical School Staff Surgeon at the Beth Israel Deaconess Hospital and the Founder of Boston Center for Facial Rejuvenation.
Catherine DiGiorgio, MD
Dr. DiGiorgio is a board-certified dermatologist and Harvard trained laser and cosmetic dermatologist, practicing at the Boston Center for Facial Rejuvenation
Omar Ibrahimi, MD, PhD
Dr. Ibrahimi is a certified Dermatologist and is the founding and medical director of the Connecticut Skin Institute.
Jeff Karp, PhD
Dr. Karp is a Professor at Harvard Medical School, Co-founder, Skintifique, Gecko Biomedical, Alivio Therapeutics, and Frequency Therapeutics.
Jeff Biernaskie, PhD
Dr. Biernaskie is an Assistant Professor of Stem Cell Biology, University of Calgary, Calgary Firefighters Burn Treatment Society Chair in Skin Regeneration and Wound Healing.
Dennis Orgill, MD, PhD
Dr. Orgill is a Vice Chair of Department of Surgery, Brigham and Women’s Hospital, Medical Director BWH Wound Care Center, and Professor at Harvard Medical School.
Henry Kay, MBA
Henry is an angel investor and board director of several Life Sciences companies who brings 40 years of business development experience in the medical industry for major companies including Boston Scientific, Allergan, Schering-Plough and Sterling Drug.
Stephen brings 25 years of experience in product strategy, development and commercialization for major companies including Pfizer, Wyeth, J&J, and ScarX Therapeutics
Wendy Hill, MSc.
Wendy has over 30 years of experience in regulatory affairs and clinical trial development in the fields of wound care, inflammation, cancer, and cardiovascular disease.
Business Development Advisor
Kristin, VP Corporate Development & Strategy, Defibtech LLC, brings 25 years’ experience in corporate strategy, M&A, and business development in medical devices and pharma.
Milica Radisic, PhD, PEng
President and Founder
Dr. Radisic is a Professor and Canada Research Chair at the University of Toronto, and founder and CEO of Quthero
David Elmaleh, PhD
Quthero, and AZTherapies
Co-Founder of Quthero and Chairman, CEO and Founder of AZTherapies.
Chintoronto Business Development Inc.
Chief Financial Officer at Chintoronto Business Development Inc.
Henry brings 40 years of business development experience in the medical industry for companies including Boston Scientific, Allergan, Schering-Plough and Sterling Drug.
Cristina Escoda, PhD, MBA
Founding Partner and Managing Director of Tachyon Ventures.
Dieter Jentsch, MBA
Retired Group Head of Global Banking and Markets and Co-CEO of ScotiaCapital Inc.